Overview
Charge detection mass spectrometry (CDMS) is reshaping the landscape for the characterization of complex biotherapeutics by transforming the analysis of large, heterogeneous biomolecular complexes and gene therapy vectors.
Join this webinar and see firsthand how industry pioneers are using electrostatic linear ion trap (ELIT)-based CDMS for direct mass and charge measurements of individual ions, delivering unprecedented insights into complex large biomolecules--from recombinant adeno-associated virus (rAAV) characterization to proteasomal complex stoichiometry.